Reducing Disparities in Medication Adherence in SLE

N/A Completed NCT03738826

Condition	Systemic Lupus Erythematosus
Phase	N/A
Sponsor	Duke University
Status	Completed
Enrollment	135 participants
Interventions	Behavioral Intervention
Start date	Oct 2, 2019
Completion date	Jun 7, 2020
Results posted	Jul 27, 2021

Summary

This is a pilot study to assess the feasibility of using Surescripts refill data during the clinical encounter to improve medication adherence in patients with systemic lupus erythematosus

Feasibility as Measured by Number of Participants With EMR (Electronic Medical Record) Documentation of Adherence

12 weeks · Participants

Behavioral Intervention	116 Participants

Acceptability as Measured by Provider Survey

12 weeks · score on a scale

Lupus Clinic Providers	4.4 ± 0.6 score on a scale

Open in BENITIONS View on ClinicalTrials.gov

Other trials for this condition

Clinical Study to Investigate the Biological Activity, Safety, Tolerability, and Pharmacok — Viatris Innovation GmbH
Efficacy and Safety of Four Doses of Cenerimod Compared to Placebo in Adult Subjects With — Viatris Innovation GmbH
A Study to Evaluate the Efficacy and Safety of Obinutuzumab in Participants With ISN/RPS 2 — Hoffmann-La Roche
Peer i-Coaching for Activated Self-Management Optimization in Adolescents and Young Adults — Duke University
Using the Cholinergic Anti-Inflammatory Pathway to Treat Systemic Lupus Musculoskeletal Pa — Northwell Health
COVID-19 Booster Vaccine in Autoimmune Disease Non-Responders — National Institute of Allergy and Infectious Diseases (NIAID)

All trials

This page summarises publicly available data from ClinicalTrials.gov. It is not medical advice and not investment advice. Always consult a qualified healthcare professional.

English 한국어 日本語中文 Русский